Protagenic Therapeutics Inc (NASDAQ:PTIX) price closed higher on current market day and jumping 266.34% above its previous close.
A look at the daily price movement shows that the last close reads $3.03. Taking into account the 52-week price action we note that the stock hit a 52-week high of $26.18 and 52-week low of $2.35. The stock added 230.49% on its value in the past month.
Protagenic Therapeutics Inc, which has a market valuation of $6.52 million, is expected to release its quarterly earnings report in June.
Technical indicators in stocks provide crucial insights into market trends, guiding investors with precise entry and exit points based on price movements for informed decision-making.On the technical perspective front, indicators give PTIX a short term outlook of 50% Sell on average. Looking at the stock’s medium term indicators we note that it is averaging as a 50% Sell, while an average of long term indicators are currently assigning the stock as 50% Buy.
The overview shows that PTIX’s price is at present 212.43% off the SMA20 and 199.73% from the SMA50. The Relative Strength Index (RSI) metric on the 14-day timeframe is pointing at 83.49, with weekly volatility standing at 36.79%. The indicator jumps to 21.44% when calculated based on the past 30 days. Protagenic Therapeutics Inc (NASDAQ:PTIX)’s beta value is holding at 0, while the average true range (ATR) indicator is currently reading 1.33.
An analysis of the Protagenic Therapeutics Inc (NASDAQ:PTIX) stock in terms of its daily trading volume indicates that the 3-month average is 446.99K.
Current records show that the company has 0.54M in outstanding shares. The insiders’ percentage holdings are 13.43% of outstanding shares while the percentage share held by institutions stands at 7.01%. But the 61.81% upside, the stock’s price has registered year-to-date as of last trading, will likely reignite investor interest given the prospect of it rallying even higher.
